Finance

Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program

Eli Lilly and Company has announced a definitive agreement to acquire Scorpion Therapeutics' PI3Kα inhibitor program STX-478. STX-478 is a once-daily oral, mutant-selective PI3Kα inhibitor currently being evaluated in...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

New SWLP laboratory at Croydon Hospital transforms the diagnostic facility into one of the most advanced and innovative in the UK

South West London Pathology (SWLP) introduces cutting-edge technologies to its laboratories to create one of the most modern, innovative, and efficient clinical blood science...

Amazon Filters launches high-temp vent filter for pharma and biotech

A UK process filter manufacturer has launched an enhanced high-temperature-resistant membrane product aimed at vent applications across the global pharmaceutical and biotechnology markets. Amazon Filters’...

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Er-Kim signs distribution agreement with the MEDICE Health Family for Vafseo in Central & Eastern Europe

Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...

Er-Kim extends exclusive distribution agreement with Ascendis to expand commercialization of endocrinology portfolio

Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma to commercialize...

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

Approvals

Manufacturiung

Finance

Research & Development
Latest

R&D

Gilead and LEO Pharma to accelerate development of oral STAT6 program with potential in inflammatory diseases

Gilead Sciences and LEO Pharma have announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer...
R&D

Newron and Myung In Pharm announce license agreement for schizophrenia treatment in South Korea

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, and Myung In...
R&D

Orna Therapeutics and Vertex Pharmaceuticals to develop next generation approaches for Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Orna Therapeutics, through its wholly owned subsidiary ReNAgade Therapeutics, has entered a three-year strategic research collaboration with Vertex Pharmaceuticals to utilize Orna’s novel and...
R&D

Antibody-drug conjugate receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK's GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate (ADC) being evaluated for...
R&D

Araris enters collaboration with Chugai to develop next-generation ADCs

Araris, a Swiss oncology biotech company developing next-generation antibody drug conjugates (ADCs), has entered a Research Collaboration and Option to License Agreement (RCO) under...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks